131 related articles for article (PubMed ID: 11506775)
1. Treatment of nosocomial pneumonia: an experience with meropenem.
Santos SS; Machado FR; Kiffer CR; Barone AA
Braz J Infect Dis; 2001 Jun; 5(3):124-9. PubMed ID: 11506775
[TBL] [Abstract][Full Text] [Related]
2. Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial.
Kollef MH; Nováček M; Kivistik Ü; Réa-Neto Á; Shime N; Martin-Loeches I; Timsit JF; Wunderink RG; Bruno CJ; Huntington JA; Lin G; Yu B; Butterton JR; Rhee EG
Lancet Infect Dis; 2019 Dec; 19(12):1299-1311. PubMed ID: 31563344
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of monotherapy by meropenem in ventilator-associated pneumonia].
Alvarez Lerma F;
Antibiot Khimioter; 2001; 46(12):42-52. PubMed ID: 12108093
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments.
Souweine B; Veber B; Bedos JP; Gachot B; Dombret MC; Regnier B; Wolff M
Crit Care Med; 1998 Feb; 26(2):236-44. PubMed ID: 9468159
[TBL] [Abstract][Full Text] [Related]
5. Meropenem monotherapy for the treatment of hospital-acquired pneumonia: results of a multicenter trial.
Berman SJ; Fogarty CM; Fabian T; Melnick D; Lesky W;
J Chemother; 2004 Aug; 16(4):362-71. PubMed ID: 15332712
[TBL] [Abstract][Full Text] [Related]
6. [Multicentre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections: results of clinical and pharmacoeconomic analysis].
Iakovlev SV; Beloborodov VB; Sidorenko SV; Iakovlev VP; Grigor'ev KB; Eliseeva EV; Kon EM; Levit AL; Kostina GV; Kuprenkov AV; Mukhacheva SIu; Saturnov AV; Sergeev IN; Spasov GP; Stakanov AV; Ushakova MA
Antibiot Khimioter; 2006; 51(7):15-27. PubMed ID: 18035730
[TBL] [Abstract][Full Text] [Related]
7. Pneumonia: the impact of risk factors on the outcome of treatment with meropenem and ceftazidime.
Finch RG; Pemberton K; Gildon KM
J Chemother; 1998 Feb; 10(1):35-46. PubMed ID: 9531074
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia.
Alvarez Lerma F;
J Chemother; 2001 Feb; 13(1):70-81. PubMed ID: 11233804
[TBL] [Abstract][Full Text] [Related]
9. Emerging trends of nosocomial pneumonia in intensive care unit of a tertiary care public teaching hospital in Western India.
Bhadade R; Harde M; deSouza R; More A; Bharmal R
Ann Afr Med; 2017; 16(3):107-113. PubMed ID: 28671150
[TBL] [Abstract][Full Text] [Related]
10. [Actualities of adults' ventilator-associated pneumonia].
Svediene S; Ivaskevicius J
Medicina (Kaunas); 2006; 42(2):91-7. PubMed ID: 16528124
[TBL] [Abstract][Full Text] [Related]
11. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.
Kollef MH; Ward S
Chest; 1998 Feb; 113(2):412-20. PubMed ID: 9498961
[TBL] [Abstract][Full Text] [Related]
12. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
Bartoloni A; Strohmeyer M; Corti G; Buonomini MI; Franchino L; Romanelli G; Moretti AM; De Vizzi GB; Petraglia A; Mancini P; Atzeni R; Fogliani V; Giura R; Paradisi F
Drugs Exp Clin Res; 1999; 25(6):243-52. PubMed ID: 10713862
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study.
Réa-Neto A; Niederman M; Lobo SM; Schroeder E; Lee M; Kaniga K; Ketter N; Prokocimer P; Friedland I
Curr Med Res Opin; 2008 Jul; 24(7):2113-26. PubMed ID: 18549664
[TBL] [Abstract][Full Text] [Related]
14. Comparing two heat and moisture exchangers, one hydrophobic and one hygroscopic, on humidifying efficacy and the rate of nosocomial pneumonia.
Thomachot L; Viviand X; Arnaud S; Boisson C; Martin CD
Chest; 1998 Nov; 114(5):1383-9. PubMed ID: 9824019
[TBL] [Abstract][Full Text] [Related]
15. Meropenem monotherapy as empiric treatment of nosocomial lower respiratory tract infection.
Sieger B
Crit Care Med; 1998 Aug; 26(8):1462-3. PubMed ID: 9710113
[No Abstract] [Full Text] [Related]
16. Effectiveness of meropenem for the treatment of aspiration pneumonia in elderly patients.
Tokuyasu H; Harada T; Watanabe E; Okazaki R; Touge H; Kawasaki Y; Shimizu E
Intern Med; 2009; 48(3):129-35. PubMed ID: 19182422
[TBL] [Abstract][Full Text] [Related]
17. Prospective randomized comparison study of piperacillin/tazobactam and meropenem for healthcare-associated pneumonia in Japan.
Yamamoto Y; Izumikawa K; Morinaga Y; Nakamura S; Kurihara S; Imamura Y; Miyazaki T; Tsukamoto M; Kakeya H; Yanagihara K; Yasuoka A; Kohno S
J Infect Chemother; 2013 Apr; 19(2):291-8. PubMed ID: 23345050
[TBL] [Abstract][Full Text] [Related]
18. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group.
Sieger B; Berman SJ; Geckler RW; Farkas SA
Crit Care Med; 1997 Oct; 25(10):1663-70. PubMed ID: 9377880
[TBL] [Abstract][Full Text] [Related]
19. Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections.
Garau J; Blanquer J; Cobo L; Corcia S; Daguerre M; de Latorre FJ; León C; Del Nogal F; Net A; Rello J
Eur J Clin Microbiol Infect Dis; 1997 Nov; 16(11):789-96. PubMed ID: 9447899
[TBL] [Abstract][Full Text] [Related]
20. [The role of meropenem in the treatment of pneumonia in the critical patient].
León Gil C; Alvarez Lerma F; Sánchez Jiménez MA
Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():62-8. PubMed ID: 9410072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
